
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $4.6B | $5.1B | $5.3B | $5.7B | $6B | |
Revenue Growth (YoY) | -19.94% | 11.05% | 3.41% | 6.94% | 5.39% | |
Cost of Revenues | $887.2M | $971.1M | $1B | $1B | $1B | |
Gross Profit | $3.7B | $4.1B | $4.3B | $4.6B | $4.9B | |
Gross Profit Margin | 80.75% | 81.02% | 81.08% | 81.83% | 82.5% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $121.2M | $144.6M | $142.8M | $165.9M | $189.3M | |
Other Inc / (Exp) | $85.3M | $1.1B | $713.6M | $746.5M | $565.3M | |
Operating Expenses | $1.7B | $1.7B | $1.7B | $1.8B | $1.8B | |
Operating Income | $2B | $2.4B | $2.6B | $2.8B | $3.1B | |
Net Interest Expenses | $784.4M | $795.7M | $761.3M | $854.6M | $905.8M | |
EBT. Incl. Unusual Items | $1.3B | $2.7B | $2.5B | $2.7B | $2.8B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$4.6M | $157.2M | $83.5M | $81.9M | $23.3M | |
Net Income to Company | $1.3B | $2.6B | $2.5B | $2.6B | $2.7B | |
Minority Interest in Earnings | -$164.8M | -$319.1M | -$312.9M | -$333.9M | -$358.1M | |
Net Income to Common Excl Extra Items | $1.1B | $2.2B | $2.1B | $2.3B | $2.4B | |
Basic EPS (Cont. Ops) | $3.59 | $6.84 | $6.52 | $6.98 | $7.26 | |
Diluted EPS (Cont. Ops) | $3.59 | $6.84 | $6.52 | $6.98 | $7.26 | |
Weighted Average Basic Share | $308.7M | $328.6M | $327.8M | $326.8M | $326.1M | |
Weighted Average Diluted Share | $308.7M | $328.6M | $327.8M | $326.8M | $326.1M | |
EBITDA | $3.4B | $4.8B | $4.6B | $4.9B | $5B | |
EBIT | $2.1B | $3.5B | $3.3B | $3.6B | $3.7B | |
Revenue (Reported) | $4.6B | $5.1B | $5.3B | $5.7B | $6B | |
Operating Income (Reported) | $2B | $2.4B | $2.6B | $2.8B | $3.1B | |
Operating Income (Adjusted) | $2.1B | $3.5B | $3.3B | $3.6B | $3.7B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $1.2B | $1.3B | $1.4B | $1.4B | $1.5B | |
Revenue Growth (YoY) | -8.38% | 4.51% | 4.24% | 6.79% | 2.11% | |
Cost of Revenues | $224M | $237.7M | $245.1M | $261.1M | $274.4M | |
Gross Profit | $1B | $1.1B | $1.1B | $1.2B | $1.2B | |
Gross Profit Margin | 81.94% | 81.66% | 81.86% | 81.9% | 81.37% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $36.1M | $33.1M | $33.3M | $37.2M | $46.9M | |
Other Inc / (Exp) | $102M | $51.6M | $42.5M | $384.2M | -$30.4M | |
Operating Expenses | $411.4M | $437.9M | $443M | $446.4M | $471M | |
Operating Income | $604.6M | $620.4M | $662.7M | $735.2M | $727.6M | |
Net Interest Expenses | $202M | $185.2M | $199.4M | $230.6M | $227M | |
EBT. Incl. Unusual Items | $504.6M | $486.9M | $505.8M | $888.8M | $470.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$5.9M | -$1.4M | -$13.5M | $47.6M | -$7.6M | |
Net Income to Company | $510.5M | $488.3M | $519.3M | $841.2M | $477.9M | |
Minority Interest in Earnings | -$63.8M | -$60.8M | -$66.6M | -$108.6M | -$63.3M | |
Net Income to Common Excl Extra Items | $446.7M | $427.5M | $452.7M | $732.5M | $414.5M | |
Basic EPS (Cont. Ops) | $1.36 | $1.30 | $1.38 | $2.25 | $1.27 | |
Diluted EPS (Cont. Ops) | $1.36 | $1.30 | $1.38 | $2.25 | $1.27 | |
Weighted Average Basic Share | $328.5M | $328.6M | $327M | $325.9M | $326.3M | |
Weighted Average Diluted Share | $328.5M | $328.6M | $327M | $325.9M | $326.3M | |
EBITDA | $1B | $996.2M | $1B | $1.4B | $1.1B | |
EBIT | $706.6M | $672M | $705.2M | $1.1B | $697.2M | |
Revenue (Reported) | $1.2B | $1.3B | $1.4B | $1.4B | $1.5B | |
Operating Income (Reported) | $604.6M | $620.4M | $662.7M | $735.2M | $727.6M | |
Operating Income (Adjusted) | $706.6M | $672M | $705.2M | $1.1B | $697.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $4.5B | $5.2B | $5.3B | $5.8B | $6B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $863.5M | $984.7M | $1B | $1B | $1B | |
Gross Profit | $3.6B | $4.2B | $4.3B | $4.7B | $5B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $116.8M | $141.7M | $142.9M | $169.8M | $199M | |
Other Inc / (Exp) | $154.9M | $1.1B | $704.5M | $1.1B | $150.7M | |
Operating Expenses | $1.7B | $1.8B | $1.7B | $1.8B | $1.9B | |
Operating Income | $1.9B | $2.4B | $2.6B | $2.9B | $3.1B | |
Net Interest Expenses | $798.8M | $778.9M | $775.5M | $885.8M | $902.2M | |
EBT. Incl. Unusual Items | $1.3B | $2.7B | $2.6B | $3.1B | $2.3B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$4.8M | $161.7M | $71.5M | $142.9M | -$32M | |
Net Income to Company | $1.3B | $2.5B | $2.5B | $2.9B | $2.4B | |
Minority Interest in Earnings | -$161.6M | -$316.2M | -$318.6M | -$375.9M | -$312.8M | |
Net Income to Common Excl Extra Items | $1.1B | $2.2B | $2.2B | $2.6B | $2.1B | |
Basic EPS (Cont. Ops) | $3.53 | $6.78 | $6.60 | $7.85 | $6.28 | |
Diluted EPS (Cont. Ops) | $3.53 | $6.78 | $6.60 | $7.85 | $6.28 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $3.4B | $4.8B | $4.6B | $5.3B | $4.6B | |
EBIT | $2.1B | $3.5B | $3.3B | $4B | $3.2B | |
Revenue (Reported) | $4.5B | $5.2B | $5.3B | $5.8B | $6B | |
Operating Income (Reported) | $1.9B | $2.4B | $2.6B | $2.9B | $3.1B | |
Operating Income (Adjusted) | $2.1B | $3.5B | $3.3B | $4B | $3.2B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $1.2B | $1.3B | $1.4B | $1.4B | $1.5B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $224M | $237.7M | $245.1M | $261.1M | $274.4M | |
Gross Profit | $1B | $1.1B | $1.1B | $1.2B | $1.2B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $36.1M | $33.1M | $33.3M | $37.2M | $46.9M | |
Other Inc / (Exp) | $102M | $51.6M | $42.5M | $384.2M | -$30.4M | |
Operating Expenses | $411.4M | $437.9M | $443M | $446.4M | $471M | |
Operating Income | $604.6M | $620.4M | $662.7M | $735.2M | $727.6M | |
Net Interest Expenses | $202M | $185.2M | $199.4M | $230.6M | $227M | |
EBT. Incl. Unusual Items | $504.6M | $486.9M | $505.8M | $888.8M | $470.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$5.9M | -$1.4M | -$13.5M | $47.6M | -$7.6M | |
Net Income to Company | $510.5M | $488.3M | $519.3M | $841.2M | $477.9M | |
Minority Interest in Earnings | -$63.8M | -$60.8M | -$66.6M | -$108.6M | -$63.3M | |
Net Income to Common Excl Extra Items | $446.7M | $427.5M | $452.7M | $732.5M | $414.5M | |
Basic EPS (Cont. Ops) | $1.36 | $1.30 | $1.38 | $2.25 | $1.27 | |
Diluted EPS (Cont. Ops) | $1.36 | $1.30 | $1.38 | $2.25 | $1.27 | |
Weighted Average Basic Share | $328.5M | $328.6M | $327M | $325.9M | $326.3M | |
Weighted Average Diluted Share | $328.5M | $328.6M | $327M | $325.9M | $326.3M | |
EBITDA | $1B | $996.2M | $1B | $1.4B | $1.1B | |
EBIT | $706.6M | $672M | $705.2M | $1.1B | $697.2M | |
Revenue (Reported) | $1.2B | $1.3B | $1.4B | $1.4B | $1.5B | |
Operating Income (Reported) | $604.6M | $620.4M | $662.7M | $735.2M | $727.6M | |
Operating Income (Adjusted) | $706.6M | $672M | $705.2M | $1.1B | $697.2M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $1B | $533.9M | $621.6M | $1.2B | $1.4B | |
Short Term Investments | -- | -- | -- | $1B | -- | |
Accounts Receivable, Net | $1.2B | $919.7M | $823.5M | $826.1M | $796.5M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $2.7B | $2.3B | $2.1B | $3.6B | $2.8B | |
Property Plant And Equipment | $512.9M | $504.1M | $496.9M | $484.1M | $519.6M | |
Long-Term Investments | $8.2B | $8.5B | $8.5B | $8.5B | $7.8B | |
Goodwill | $20.1M | $20.1M | $20.1M | $20.1M | $20.1M | |
Other Intangibles | $35M | $33.3M | $17.8M | $8.7M | $2.7M | |
Other Long-Term Assets | -- | -- | -- | -- | $1.4B | |
Total Assets | $34.8B | $33.8B | $33B | $34.3B | $32.4B | |
Accounts Payable | $1.3B | $1.4B | $1.5B | $1.7B | $1.7B | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $4B | $3.5B | $3.2B | $3.5B | $3.4B | |
Long-Term Debt | $26B | $24.8B | $24.9B | $26B | $24.2B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $31.1B | $29.4B | $29.2B | $30.6B | $28.8B | |
Common Stock | $42.1M | $41.8M | $41.5M | $41.1M | $40.8M | |
Other Common Equity Adj | -$188.7M | -$185.2M | -$164.9M | -$172.8M | -$193M | |
Common Equity | $3B | $3.3B | $3.1B | $3B | $2.9B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $618.8M | $1B | $685.4M | $664.8M | $657.5M | |
Total Equity | $3.7B | $4.4B | $3.8B | $3.7B | $3.6B | |
Total Liabilities and Equity | $34.8B | $33.8B | $33B | $34.3B | $32.4B | |
Cash and Short Terms | $1B | $533.9M | $621.6M | $2.2B | $1.4B | |
Total Debt | $26.7B | $25.3B | $24.9B | $26B | $24.2B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $935.8M | $514.9M | $1.2B | $1.3B | $1.4B | |
Short Term Investments | -- | -- | -- | $1.3B | -- | |
Accounts Receivable, Net | $1B | $819.8M | $779.7M | $793.4M | $779.9M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $2.3B | $1.7B | $1.9B | $3.3B | $2.2B | |
Property Plant And Equipment | $510.6M | $501.9M | $494.6M | $524.9M | $517.5M | |
Long-Term Investments | $7.6B | $8B | $8B | $7.2B | $7B | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $1.1B | $1.1B | $1.1B | $1.1B | $1.3B | |
Total Assets | $34.4B | $33.5B | $33.3B | $33.7B | $32.5B | |
Accounts Payable | $1.2B | $1.2B | $1.4B | $1.5B | $1.5B | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $3.3B | $3B | $3.1B | $3.3B | $3.2B | |
Long-Term Debt | $26.2B | $25.2B | $25.6B | $25.5B | $24.8B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $30.4B | $29.2B | $29.6B | $29.9B | $29.2B | |
Common Stock | $42M | $41.7M | $41.4M | $41.1M | $40.7M | |
Other Common Equity Adj | -$183.9M | -$170.1M | -$160.9M | -$165.8M | -$219.7M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $963.3M | $1B | $673.8M | $656M | $662M | |
Total Equity | $4B | $4.3B | $3.7B | $3.8B | $3.3B | |
Total Liabilities and Equity | $34.4B | $33.5B | $33.3B | $33.7B | $32.5B | |
Cash and Short Terms | $935.8M | $514.9M | $1.2B | $2.6B | $1.4B | |
Total Debt | $26.2B | $25.2B | $25.6B | $25.5B | $24.8B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $1.3B | $2.6B | $2.5B | $2.6B | $2.7B | |
Depreciation & Amoritzation | $1.4B | $1.3B | $1.3B | $1.3B | $1.4B | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$415.9M | $265.4M | $63.4M | -$11.8M | $36.2M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $2.3B | $3.6B | $3.8B | $3.9B | $3.8B | |
Capital Expenditures | $484.1M | $527.9M | $650M | $793.3M | $755.6M | |
Cash Acquisitions | -$3.8B | -$314M | -$439.2M | -$149.8M | -$168.8M | |
Cash From Investing | -$4B | -$552.8M | -$626.6M | -$1.4B | $1.4B | |
Dividends Paid (Ex Special Dividend) | -$1.7B | -$2.7B | -$2.6B | -$2.8B | -$3B | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $15.2B | $9.3B | $3.4B | $3.6B | $1.1B | |
Long-Term Debt Repaid | -$13B | -$10.1B | -$3.7B | -$2.7B | -$3B | |
Repurchase of Common Stock | -$169.5M | -$4.9M | -$189.4M | -$162.7M | -$60.7M | |
Other Financing Activities | -$8.1M | -$379.3M | $1.9M | -$32.1M | -$11.2M | |
Cash From Financing | $2B | -$3.6B | -$3.1B | -$2B | -$5B | |
Beginning Cash (CF) | $669.4M | $1B | $533.9M | $621.6M | $1.2B | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $342.2M | -$477.7M | $87.7M | $547.4M | $231.4M | |
Ending Cash (CF) | $1B | $533.9M | $621.6M | $1.2B | $1.4B | |
Levered Free Cash Flow | $1.8B | $3.1B | $3.1B | $3.1B | $3.1B |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $705.9M | $569.5M | $557.5M | $569.4M | -- | |
Depreciation & Amoritzation | $333M | $315.3M | $339.1M | $332.6M | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | $55.3M | -$27.8M | $36.6M | -$3.8M | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $1B | $1.1B | $1.1B | $1.1B | -- | |
Capital Expenditures | $113.9M | $154.7M | $221.2M | $188.4M | -- | |
Cash Acquisitions | -$108.1M | -$125.2M | -$4.9M | -$6.9M | -- | |
Cash From Investing | -$194.5M | -$126.7M | -$153.2M | -$105.2M | -- | |
Dividends Paid (Ex Special Dividend) | -$489.5M | -$640M | -$694.1M | -$751.2M | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $1.5B | $92.9M | $196.9M | $2.2M | -- | |
Long-Term Debt Repaid | -$1.5B | -$260.7M | -$785.2M | -$218.9M | -- | |
Repurchase of Common Stock | -$2.4M | -$148.8M | -$11.1M | -$6.4M | -- | |
Other Financing Activities | $14.2M | $8.8M | -$704K | -$439K | -- | |
Cash From Financing | -$452.5M | -$947.9M | -$1.3B | -$974.6M | -- | |
Beginning Cash (CF) | $935.8M | $514.9M | $1.2B | $1.3B | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $355M | $26.3M | -$318M | -$16.7M | -- | |
Ending Cash (CF) | $1.3B | $541.2M | $837.5M | $1.2B | -- | |
Levered Free Cash Flow | $888.1M | $946.2M | $908.3M | $874.8M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $1.3B | $2.5B | $2.5B | $2.9B | $2.4B | |
Depreciation & Amoritzation | $1.3B | $1.3B | $1.3B | $1.3B | $1.4B | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$257M | $151.6M | -$834K | -$7.2M | $40.8M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $2.5B | $3.6B | $3.8B | $3.9B | $3.9B | |
Capital Expenditures | $385.7M | $567.8M | $661.4M | $790.2M | $822.8M | |
Cash Acquisitions | -$3.7B | -$362.6M | -$353.1M | -$139.3M | -$539M | |
Cash From Investing | -$3.9B | -$514.6M | -$686.4M | -$510.1M | $337.1M | |
Dividends Paid (Ex Special Dividend) | -$1.4B | -$2.8B | -$2.6B | -$2.9B | -$3.1B | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $12.4B | $8.1B | $2.4B | $2.3B | $1.9B | |
Long-Term Debt Repaid | -$13.8B | -$8.7B | -$2.1B | -$2.5B | -$2.8B | |
Repurchase of Common Stock | -$930K | -$8.7M | -$190.9M | -$202.4M | -$23.4M | |
Other Financing Activities | -$353.5M | -$25.7M | -$754K | -$37.9M | -$5.7M | |
Cash From Financing | -$1.3B | -$3.5B | -$2.5B | -$3.3B | -$4.1B | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$2.8B | -$420.9M | $640.5M | $95.7M | $128.9M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $2.1B | $3B | $3.1B | $3.1B | $3B |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $1.2B | $1.1B | $1.1B | $1.4B | $477.9M | |
Depreciation & Amoritzation | $664.8M | $639.5M | $661.4M | $657.4M | $355.6M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | $259M | $62.1M | $62.4M | $26.6M | $35.1M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $1.9B | $1.9B | $2B | $1.8B | $827.2M | |
Capital Expenditures | $228.7M | $309.3M | $387.3M | $351.3M | $230.2M | |
Cash Acquisitions | -$183.8M | -$249.6M | -$43.3M | -$34.9M | -$398.2M | |
Cash From Investing | -$332.6M | -$226.6M | -$313M | $588.2M | -$377.9M | |
Dividends Paid (Ex Special Dividend) | -$977.8M | -$1.3B | -$1.4B | -$1.5B | -$793.3M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $5.1B | $2.5B | $1.6B | $70.1M | $857.1M | |
Long-Term Debt Repaid | -$5.3B | -$2.8B | -$1.7B | -$888.8M | -$526.1M | |
Repurchase of Common Stock | -$2.5M | -$152.8M | -$16.7M | -$51.6M | -$8M | |
Other Financing Activities | -$335.8M | $12.4M | $230K | -$5.3M | $694K | |
Cash From Financing | -$1.3B | -$1.7B | -$1.4B | -$2.4B | -$469.7M | |
Beginning Cash (CF) | $1.9B | $1B | $1.8B | $2.4B | $1.4B | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $279.2M | $7.3M | $215.8M | $65.4M | -$20.3M | |
Ending Cash (CF) | $2.2B | $1.1B | $2B | $2.5B | $1.4B | |
Levered Free Cash Flow | $1.6B | $1.6B | $1.6B | $1.5B | $597M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.